{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:53:23Z","timestamp":1793944403117,"version":"4.8.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T00:00:00Z","timestamp":1406505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.clinthera.2014.07.017","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T14:33:51Z","timestamp":1408631631000},"page":"1465-1479","source":"Crossref","is-referenced-by-count":380,"title":["Mechanism of Action of Colchicine in the Treatment of Gout"],"prefix":"10.1016","volume":"36","author":[{"given":"Nicola","family":"Dalbeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Lauterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.07.017_bib1","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1001\/jama.1987.03390140090033","article-title":"Colchicine in acute gout. Reassessment of risks and benefits","volume":"257","author":"Roberts","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2014.07.017_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib3","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib5","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2014.07.017_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3810\/pgm.2011.11.2511","article-title":"2011 Recommendations for the diagnosis and management of gout and hyperuricemia","volume":"123","author":"Hamburger","year":"2011","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0046-8177(73)80013-9","article-title":"The synovitis of acute gouty arthritis. A light and electron microscopic study","volume":"4","author":"Agudelo","year":"1973","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.immuni.2008.09.013","article-title":"Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells","volume":"29","author":"Ng","year":"2008","journal-title":"Immunity"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2014.07.017_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ard.42.Suppl_1.12","article-title":"Studies of urate crystallisation in relation to gout","volume":"42","author":"Fiddis","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0022-5347(17)39003-1","article-title":"Solubility of uric acid and supersaturation of monosodium urate: why is uric acid so highly soluble in urine?","volume":"142","author":"Iwata","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/ard.33.4.313","article-title":"Factors affecting urate solubility in vitro","volume":"33","author":"Kippen","year":"1974","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780150209","article-title":"The influence of temperature on the solubility of monosodium urate","volume":"15","author":"Loeb","year":"1972","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF02474201","article-title":"Solubility of uric acid and monosodium urate","volume":"10","author":"Wilcox","year":"1972","journal-title":"Med Biol Eng"},{"key":"10.1016\/j.clinthera.2014.07.017_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1098\/rspb.1988.0069","article-title":"A structural approach to pathological crystallizations. Gout: the possible role of albumin in sodium urate crystallization","volume":"235","author":"Perl-Treves","year":"1988","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.clinthera.2014.07.017_bib15","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1096\/fasebj.6.8.1592211","article-title":"Antibodies against crystals","volume":"6","author":"Kam","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.clinthera.2014.07.017_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmr.300070404","article-title":"Specificity in the recognition of crystals by antibodies","volume":"7","author":"Kam","year":"1994","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.clinthera.2014.07.017_bib17","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.0803777","article-title":"A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity","volume":"182","author":"Kanevets","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/anr.1780321114","article-title":"Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes","volume":"32","author":"Guerne","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib19","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/art.10614","article-title":"Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages","volume":"46","author":"Landis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.24185","article-title":"Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout","volume":"60","author":"Martin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib21","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.10326","article-title":"Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events","volume":"46","author":"Schiltz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib22","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.4049\/jimmunol.138.10.3213","article-title":"Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1","volume":"138","author":"Di Giovine","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2014.07.017_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrm1019","article-title":"NALPs: a novel protein family involved in inflammation","volume":"4","author":"Tschopp","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature02664","article-title":"Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf","volume":"430","author":"Mariathasan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2014.07.017_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2014.07.017_bib27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2014.07.017_bib28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib30","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","article-title":"Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration","volume":"14","author":"Petrilli","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clinthera.2014.07.017_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","article-title":"A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes","volume":"356","author":"Thornberry","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2014.07.017_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2443.2004.00789.x","article-title":"ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules","volume":"9","author":"Yamamoto","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.clinthera.2014.07.017_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib35","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.30249","article-title":"Monosodium urate monohydrate crystal-recruited noninflammatory monocytes differentiate into M1-like proinflammatory macrophages in a peritoneal murine model of gout","volume":"63","author":"Martin","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib36","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/rheumatology\/ker524","article-title":"Microcrystals as DAMPs and their role in joint inflammation","volume":"51","author":"Busso","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2014.07.017_bib37","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","article-title":"Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation","volume":"52","author":"Liu-Bryan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI115142","article-title":"Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution","volume":"87","author":"Di Giovine","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib39","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood.V91.5.1769","article-title":"Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes","volume":"91","author":"Pouliot","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2014.07.017_bib40","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.1780340716","article-title":"Monocyte-derived neutrophil chemotactic factor\/interleukin-8 is a potential mediator of crystal-induced inflammation","volume":"34","author":"Terkeltaub","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.33355","article-title":"NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout","volume":"64","author":"Amaral","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib42","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1172\/JCI116373","article-title":"Crystal-induced neutrophil activation. III. Inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils","volume":"91","author":"Gaudry","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jlb.59.6.864","article-title":"Paradoxical effects of colchicine on the activation of human neutrophils by chemotactic factors and inflammatory microcrystal","volume":"59","author":"Roberge","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib44","doi-asserted-by":"crossref","first-page":"e29318","DOI":"10.1371\/journal.pone.0029318","article-title":"Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout","volume":"6","author":"Mitroulis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2014.07.017_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fimmu.2012.00376","article-title":"Bonding the foe - NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals","volume":"3","author":"Schorn","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(24)37005-3","article-title":"Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins","volume":"283","author":"Getting","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2014.07.017_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jcp.1041650106","article-title":"Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression","volume":"165","author":"Meng","year":"1995","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0090-1229(83)90143-5","article-title":"Activation of the alternative pathway of complement by monosodium urate crystals","volume":"26","author":"Fields","year":"1983","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib49","first-page":"425","article-title":"Effect of IgG and C-reactive protein on complement depletion by monosodium urate crystals","volume":"10","author":"Russell","year":"1983","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI109360","article-title":"Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals","volume":"63","author":"Giclas","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0090-1229(82)90235-5","article-title":"Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface","volume":"24","author":"Russell","year":"1982","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib52","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.20386","article-title":"Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis","volume":"50","author":"Tramontini","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib53","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1189\/jlb.0907654","article-title":"Crucial role of neutrophils in the development of mechanical inflammatory hypernociception","volume":"83","author":"Cunha","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1744-8069-6-63","article-title":"Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1beta maturation","volume":"6","author":"Cunha","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.clinthera.2014.07.017_bib55","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1172\/JCI111380","article-title":"Lipoproteins containing apolipoprotein B are a major regulator of neutrophil responses to monosodium urate crystals","volume":"73","author":"Terkeltaub","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1172\/JCI114971","article-title":"Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo","volume":"87","author":"Terkeltaub","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib57","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/34.8.724","article-title":"A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout","volume":"34","author":"Pascual","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib58","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/014107688407700907","article-title":"Crystal deposition in the knee and great toe joints of asymptomatic gout patients","volume":"77","author":"Kennedy","year":"1984","journal-title":"J R Soc Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-91-1-56","article-title":"Urate crystals in asymptomatic metatarsophalangeal joints","volume":"91","author":"Weinberger","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archinte.1963.03620250103014","article-title":"Significance of urate crystals in synovial fluids","volume":"111","author":"Zvaifler","year":"1963","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.10709","article-title":"Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals","volume":"48","author":"Akahoshi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2014.07.017_bib63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2014.07.017_bib64","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.1780390718","article-title":"Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1","volume":"39","author":"Liote","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib65","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF","volume":"101","author":"Fadok","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib66","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/art.37822","article-title":"Neutrophil cannibalism triggers transforming growth factor beta1 production and self regulation of neutrophil inflammatory function in monosodium urate monohydrate crystal-induced inflammation in mice","volume":"65","author":"Steiger","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib67","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/art.20317","article-title":"Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation","volume":"50","author":"Yagnik","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/annrheumdis-2011-200711","article-title":"Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor beta1 in the resolution phase","volume":"71","author":"Scanu","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib69","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/ard.2010.145821","article-title":"Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFbeta1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3","volume":"70","author":"Chen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib70","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1016\/j.yexcr.2009.08.020","article-title":"Microtubule-mediated NF-kappaB activation in the TNF-alpha signaling pathway","volume":"315","author":"Jackman","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.clinthera.2014.07.017_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.171.3.715","article-title":"Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents","volume":"171","author":"Ding","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib72","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib73","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine","volume":"153","author":"Chia","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib74","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.4049\/jimmunol.174.8.4584","article-title":"Microtubule disruption suppresses allergic response through the inhibition of calcium influx in the mast cell degranulation pathway","volume":"174","author":"Oka","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08860220500461286","article-title":"The effect of colchicine on the peritoneal membrane","volume":"28","author":"Sayarlioglu","year":"2006","journal-title":"Ren Fail"},{"key":"10.1016\/j.clinthera.2014.07.017_bib76","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.4049\/jimmunol.152.10.5060","article-title":"Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process","volume":"152","author":"Kuijpers","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib77","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1189\/jlb.1012510","article-title":"Technical advance: Inhibition of neutrophil chemotaxis by colchicine is modulated through viscoelastic properties of subcellular compartments","volume":"94","author":"Paschke","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2125.1994.tb04328.x","article-title":"Colchicine concentration in leukocytes of patients with familial Mediterranean fever","volume":"38","author":"Chappey","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib79","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1016\/S0021-9258(19)41207-6","article-title":"Binding of colchicine to purified microtubule protein","volume":"250","author":"Sherline","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinthera.2014.07.017_bib80","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1073\/pnas.79.22.6753","article-title":"Tubulin bound to colchicine forms polymers different from microtubules","volume":"79","author":"Andreu","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2014.07.017_bib81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0163-7258(91)90027-J","article-title":"Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents","volume":"49","author":"Luduena","year":"1991","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2014.07.017_bib82","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tcb.2006.08.002","article-title":"Microtubule motors at the intersection of trafficking and transport","volume":"16","author":"Caviston","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib83","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI116759","article-title":"Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine","volume":"92","author":"Roberge","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00917514","article-title":"Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules","volume":"16","author":"Asako","year":"1992","journal-title":"Inflammation"},{"key":"10.1016\/j.clinthera.2014.07.017_bib85","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0896-6273(03)00473-2","article-title":"Role of the sensory neuron cytoskeleton in second messenger signaling for inflammatory pain","volume":"39","author":"Dina","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.clinthera.2014.07.017_bib86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1179\/1743132813Y.0000000261","article-title":"Role of colchicine-induced microtubule depolymerization in hyperalgesia via TRPV in rats with chronic compression of the dorsal root ganglion","volume":"36","author":"Ning","year":"2014","journal-title":"Neurol Res"},{"key":"10.1016\/j.clinthera.2014.07.017_bib87","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/PL00005251","article-title":"Effect of colchicine on nerve growth factor-induced leukocyte accumulation and thermal hyperalgesia in the rat","volume":"358","author":"Schuligoi","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib88","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/ken460","article-title":"Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout","volume":"48","author":"Dalbeth","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2014.07.017_bib89","doi-asserted-by":"crossref","first-page":"e32705","DOI":"10.1371\/journal.pone.0032705","article-title":"TRAF6 mediates IL-1beta\/LPS-induced suppression of TGF-beta signaling through its interaction with the type III TGF-beta receptor","volume":"7","author":"Lim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2014.07.017_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00232-011-9342-1","article-title":"Colchicine Modulates Oxidative Stress in Serum and Leucocytes from Remission Patients with Family Mediterranean Fever Through Regulation of Ca2+ Release and the Antioxidant System","volume":"240","author":"Sahin","year":"2011","journal-title":"J Membr Biol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib91","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1002\/jcb.24231","article-title":"The effect of colchicine on pyrin and pyrin interacting proteins","volume":"113","author":"Taskiran","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.clinthera.2014.07.017_bib92","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0736-4679(02)00430-4","article-title":"Deaths associated with inappropriate intravenous colchicine administration","volume":"22","author":"Bonnel","year":"2002","journal-title":"J Emerg Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib93","series-title":"Colcrys [package insert]","year":"2009"},{"key":"10.1016\/j.clinthera.2014.07.017_bib94","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/j.1552-4604.1996.tb04753.x","article-title":"Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses","volume":"36","author":"Ferron","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-2952(96)00693-4","article-title":"Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation","volume":"53","author":"Tateishi","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib96","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1124\/dmd.109.028282","article-title":"Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine","volume":"37","author":"Dahan","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2014.07.017_bib97","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0736-4679(00)00160-8","article-title":"Colchicine-induced bone marrow suppression: treatment with granulocyte colony-stimulating factor","volume":"18","author":"Harris","year":"2000","journal-title":"J Emerg Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib98","first-page":"189","article-title":"Severe respiratory muscle weakness related to long-term colchicine therapy","volume":"49","author":"Tanios","year":"2004","journal-title":"Respir Care"},{"key":"10.1016\/j.clinthera.2014.07.017_bib99","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","article-title":"Colchicine myopathy and neuropathy","volume":"316","author":"Kuncl","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib100","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib101","unstructured":"US Food and Drug Administration. Information for Healthcare Professionals: New Safety Information for Colchicine (marketed as Colcrys). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm174315.htm. Accessed June 5, 2014."},{"key":"10.1016\/j.clinthera.2014.07.017_bib102","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1345\/aph.1E593","article-title":"Acute myopathy in a patient with concomitant use of pravastatin and colchicine","volume":"39","author":"Alayli","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2014.07.017_bib103","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1345\/aph.1E653","article-title":"Possible colchicine rhabdomyolysis in a fluvastatin-treated patient","volume":"39","author":"Atasoyu","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2014.07.017_bib104","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/RHU.0b013e318156d977","article-title":"Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine","volume":"13","author":"Justiniano","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/pmj.77.905.191","article-title":"Colchicine induced rhabdomyolysis","volume":"77","author":"Chattopadhyay","year":"2001","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clinthera.2014.07.017_bib106","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.clinthera.2014.07.017_bib107","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1081\/CLT-100100916","article-title":"Fatal cardiovascular collapse following acute colchicine ingestion","volume":"38","author":"Mullins","year":"2000","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01707666","article-title":"Cardiotoxicity of colchicine in the rat","volume":"20","author":"Mery","year":"1994","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib109","first-page":"513","article-title":"A double-blind randomized controlled trial appraising the symptom-modifying effects of colchicine on osteoarthritis of the knee","volume":"29","author":"Aran","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib110","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/art.30360","article-title":"Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis","volume":"63","author":"Attur","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib111","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1113\/expphysiol.2012.068338","article-title":"The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1beta","volume":"98","author":"Bracey","year":"2013","journal-title":"Exp Physiol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib112","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.10455","article-title":"A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report","volume":"47","author":"Das","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib113","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jbspin.2012.03.013","article-title":"Gout and osteoarthritis: A pathogenetic link?","volume":"79","author":"Roddy","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clinthera.2014.07.017_bib114","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O","article-title":"Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis","volume":"41","author":"Melchiorri","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C","article-title":"Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes","volume":"44","author":"Tetlow","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib116","first-page":"237","article-title":"The role of cytokines in osteoarthritis pathophysiology","volume":"39","author":"Fernandes","year":"2002","journal-title":"Biorheology"},{"key":"10.1016\/j.clinthera.2014.07.017_bib117","first-page":"251","article-title":"TGF-b signaling in cartilage homeostasis and osteoarthritis","volume":"4","author":"Finnson","year":"2012"},{"key":"10.1016\/j.clinthera.2014.07.017_bib118","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.joca.2007.04.011","article-title":"Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes","volume":"15","author":"Roman-Blas","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.clinthera.2014.07.017_bib119","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780281113","article-title":"Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids. Elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease","volume":"28","author":"Rachow","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.39.3.222","article-title":"Formation of calcium pyrophosphate crystals in vitro: implications for calcium pyrophosphate crystal deposition disease (pseudogout)","volume":"39","author":"Hearn","year":"1980","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib121","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI108239","article-title":"Factors affecting the solubility of calcium pyrophosphate dihydrate crystals","volume":"56","author":"Bennett","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.07.017_bib122","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2952","article-title":"Mechanisms of inflammation in gout","volume":"12","author":"Busso","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2014.07.017_bib123","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.2010.139360","article-title":"EULAR recommendations for calcium pyrophosphate deposition. Part II: management","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib124","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar4250","article-title":"Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications","volume":"15","author":"Gagne","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2014.07.017_bib125","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.4049\/jimmunol.1203215","article-title":"Pseudogout-associated inflammatory calcium pyrophosphate dihydrate microcrystals induce formation of neutrophil extracellular traps","volume":"190","author":"Pang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib126","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.52.11.826","article-title":"Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis","volume":"52","author":"McKendry","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib127","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM196210042671402","article-title":"Responses to Colchicine Therapeutic Trial in Rheumatoid Arthritis","volume":"267","author":"Zuckner","year":"1962","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.clinthera.2014.07.017_bib128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","article-title":"Prevalence of contraindications and prescription of pharmacologic therapies for gout","volume":"124","author":"Keenan","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2014.07.017_bib129","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2014.07.017_bib130","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2014.07.017_bib131","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib132","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","article-title":"Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial","volume":"33","author":"Raju","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.clinthera.2014.07.017_bib133","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1160\/TH12-04-0248","article-title":"Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options","volume":"108","author":"Martin-Ventura","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2014.07.017_bib134","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2014.07.017_bib135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814004573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814004573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T09:06:44Z","timestamp":1746349604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814004573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":135,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0149291814004573"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.07.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}